Open AccessAcupuncture combined with tamsulosin hydrochloride sustained-release capsule in the treatment of chronic prostatitis/chronic pelvic pain syndrome
Author(s) -
Jisheng Wang,
Jie Yang,
Sheng Deng,
Xiaohua Yu,
Binghao Bao,
Ruijia Liu,
Haisong Li
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000019540
Subject(s) - medicine , prostatitis , chronic prostatitis/chronic pelvic pain syndrome , acupuncture , randomized controlled trial , randomization , tamsulosin , physical therapy , pelvic pain , clinical trial , traditional chinese medicine , alternative medicine , surgery , prostate , pathology , cancer , hyperplasia
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urinary system disease in men. As part of traditional Traditional Chinese medicine, acupuncture has been widely used in clinical practice. In order to evaluate the exact effect of acupuncture on the clinical efficacy of CP/CPPS, this experiment uses randomized controlled experiments. Methods/design: This pragmatic randomized controlled trial will recruit 166 patients who are diagnosed with CP/CPPS. Simple randomization to conventional drug treatment with a 1:1 allocation ratio will be used. Ten 30-minute acupuncture sessions will be provided to patients assigned to the Intervention group. All participants will continue to receive conventional drug treatment. The selection of outcomes will be evaluated by Health's Symptom Score Index (NIH-CPSI) score at week 4. Discussion: This trial may provide evidence regarding the clinical effectiveness, safety, and cost-effectiveness of acupuncture for patients with CP/CPPS. Trial registration: ClinicalTrials.gov, ChiCTR1900021132, Registered on 29 January 2019